Biodesix Historical Income Statement

BDSX Stock

USD 1.44 0.01 0.70%

Historical analysis of Biodesix income statement accounts such as Depreciation And Amortization of 3.2 M, Interest Expense of 6.5 M or Selling General Administrative of 49.7 M can show how well Biodesix performed in making a profits. Evaluating Biodesix income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Biodesix's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Biodesix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biodesix is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

About Biodesix Income Statement Analysis

Biodesix Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Biodesix shareholders. The income statement also shows Biodesix investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Biodesix Income Statement Chart

At this time, Biodesix's Interest Income is fairly stable compared to the past year. Research Development is likely to rise to about 12 M in 2024, despite the fact that Net Interest Income is likely to grow to (9.3 M).

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Net Income From Continuing Ops Ebit

Total Revenue

Total revenue comprises all receipts Biodesix generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Biodesix minus its cost of goods sold. It is profit before Biodesix operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Biodesix's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Biodesix current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.At this time, Biodesix's Interest Income is fairly stable compared to the past year. Research Development is likely to rise to about 12 M in 2024, despite the fact that Net Interest Income is likely to grow to (9.3 M).

	2023	2024 (projected)
Depreciation And Amortization	5.5M	3.2M
Interest Income	16.2K	25.9K

Depreciation And Amortization Interest Income

Biodesix income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense
Net Interest Income		0.36	-0.87	-0.97	-0.88	-0.85	-0.81	-0.91	-0.85	0.78	0.9	0.83	-0.71	0.79	-0.62	-0.87	-0.89	0.86	0.8	0.82	-0.77
Interest Income	0.36		-0.64	-0.41	-0.33	-0.35	-0.36	-0.31	-0.35	0.34	0.26	0.29	-0.08	0.25	-0.34	-0.31	-0.23	0.26	0.03	0.28	-0.31
Depreciation And Amortization	-0.87	-0.64		0.9	0.9	0.91	0.81	0.92	0.84	-0.78	-0.81	-0.77	0.54	-0.73	0.6	0.87	0.84	-0.77	-0.55	-0.72	0.64
Interest Expense	-0.97	-0.41	0.9		0.89	0.89	0.82	0.92	0.86	-0.75	-0.85	-0.81	0.69	-0.78	0.62	0.89	0.92	-0.83	-0.79	-0.82	0.81
Selling General Administrative	-0.88	-0.33	0.9	0.89		0.99	0.85	0.93	0.95	-0.93	-0.94	-0.94	0.79	-0.93	0.66	1.0	0.97	-0.94	-0.69	-0.9	0.77
Selling And Marketing Expenses	-0.85	-0.35	0.91	0.89	0.99		0.83	0.93	0.94	-0.9	-0.91	-0.91	0.75	-0.9	0.64	0.99	0.97	-0.91	-0.67	-0.88	0.76
Total Revenue	-0.81	-0.36	0.81	0.82	0.85	0.83		0.87	0.96	-0.73	-0.75	-0.76	0.84	-0.73	0.94	0.87	0.76	-0.75	-0.42	-0.7	0.56
Gross Profit	-0.91	-0.31	0.92	0.92	0.93	0.93	0.87		0.89	-0.75	-0.85	-0.78	0.66	-0.74	0.65	0.92	0.9	-0.8	-0.62	-0.72	0.6
Other Operating Expenses	-0.85	-0.35	0.84	0.86	0.95	0.94	0.96	0.89		-0.88	-0.88	-0.91	0.9	-0.9	0.86	0.97	0.89	-0.9	-0.57	-0.86	0.72
Operating Income	0.78	0.34	-0.78	-0.75	-0.93	-0.9	-0.73	-0.75	-0.88		0.96	0.99	-0.81	0.98	-0.6	-0.94	-0.9	0.98	0.68	0.95	-0.8
Net Income From Continuing Ops	0.9	0.26	-0.81	-0.85	-0.94	-0.91	-0.75	-0.85	-0.88	0.96		0.96	-0.79	0.94	-0.56	-0.95	-0.94	0.98	0.8	0.93	-0.8
Ebit	0.83	0.29	-0.77	-0.81	-0.94	-0.91	-0.76	-0.78	-0.91	0.99	0.96		-0.87	1.0	-0.63	-0.95	-0.94	1.0	0.76	0.98	-0.87
Research Development	-0.71	-0.08	0.54	0.69	0.79	0.75	0.84	0.66	0.9	-0.81	-0.79	-0.87		-0.88	0.84	0.84	0.77	-0.85	-0.58	-0.86	0.74
Ebitda	0.79	0.25	-0.73	-0.78	-0.93	-0.9	-0.73	-0.74	-0.9	0.98	0.94	1.0	-0.88		-0.61	-0.94	-0.93	0.99	0.76	0.99	-0.88
Cost Of Revenue	-0.62	-0.34	0.6	0.62	0.66	0.64	0.94	0.65	0.86	-0.6	-0.56	-0.63	0.84	-0.61		0.7	0.55	-0.59	-0.2	-0.58	0.45
Total Operating Expenses	-0.87	-0.31	0.87	0.89	1.0	0.99	0.87	0.92	0.97	-0.94	-0.95	-0.95	0.84	-0.94	0.7		0.97	-0.95	-0.7	-0.92	0.79
Reconciled Depreciation	-0.89	-0.23	0.84	0.92	0.97	0.97	0.76	0.9	0.89	-0.9	-0.94	-0.94	0.77	-0.93	0.55	0.97		-0.95	-0.84	-0.93	0.86
Income Before Tax	0.86	0.26	-0.77	-0.83	-0.94	-0.91	-0.75	-0.8	-0.9	0.98	0.98	1.0	-0.85	0.99	-0.59	-0.95	-0.95		0.8	0.98	-0.87
Total Other Income Expense Net	0.8	0.03	-0.55	-0.79	-0.69	-0.67	-0.42	-0.62	-0.57	0.68	0.8	0.76	-0.58	0.76	-0.2	-0.7	-0.84	0.8		0.83	-0.89
Net Income	0.82	0.28	-0.72	-0.82	-0.9	-0.88	-0.7	-0.72	-0.86	0.95	0.93	0.98	-0.86	0.99	-0.58	-0.92	-0.93	0.98	0.83		-0.94
Income Tax Expense	-0.77	-0.31	0.64	0.81	0.77	0.76	0.56	0.6	0.72	-0.8	-0.8	-0.87	0.74	-0.88	0.45	0.79	0.86	-0.87	-0.89	-0.94

Click cells to compare fundamentals

Biodesix Account Relationship Matchups

Biodesix income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Net Interest Income	(3.0M)	(7.6M)	(4.5M)	(8.1M)	(9.8M)	(9.3M)
Depreciation And Amortization	469K	2.9M	3.2M	3.6M	5.5M	3.2M
Interest Expense	3.0M	7.6M	4.5M	8.1M	9.5M	6.5M
Selling General Administrative	30.6M	34.9M	50.5M	61.5M	67.8M	49.7M
Selling And Marketing Expenses	30.6M	34.9M	50.5M	61.5M	70.7M	44.7M
Total Revenue	24.6M	45.6M	54.5M	38.2M	49.1M	42.6M
Gross Profit	18.5M	23.6M	24.0M	24.1M	36.1M	26.1M
Other Operating Expenses	47.2M	67.7M	93.8M	88.7M	90.4M	78.2M
Operating Income	(22.6M)	(22.1M)	(39.3M)	(50.5M)	(41.3M)	(43.4M)
Net Income From Continuing Ops	(30.7M)	(31.4M)	(43.2M)	(65.4M)	(63.3M)	(66.5M)
Ebit	(22.6M)	(23.7M)	(38.7M)	(57.4M)	(42.6M)	(44.7M)
Research Development	10.5M	10.8M	12.8M	13.1M	10.0M	12.0M
Ebitda	(22.2M)	(20.8M)	(35.5M)	(53.8M)	(37.1M)	(39.0M)
Cost Of Revenue	6.1M	22.0M	30.5M	14.2M	13.0M	16.5M
Total Operating Expenses	41.1M	45.7M	63.3M	74.6M	77.4M	61.6M
Reconciled Depreciation	2.8M	2.9M	3.2M	5.8M	5.8M	4.1M
Income Before Tax	(30.7M)	(31.4M)	(43.2M)	(65.4M)	(52.1M)	(54.8M)
Total Other Income Expense Net	(8.1M)	(8.4M)	(2.2M)	(14.9M)	(10.8M)	(11.3M)
Net Income Applicable To Common Shares	(30.7M)	(31.4M)	(43.2M)	(65.4M)	(58.9M)	(61.8M)
Net Income	(31.4M)	(36.5M)	(44.5M)	(80.4M)	(52.1M)	(54.8M)
Income Tax Expense	629K	5.1M	1.3M	14.9M	5.3M	5.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biodesix Historical Income Statement

About Biodesix Income Statement Analysis

Biodesix Income Statement Chart

Total Revenue

Gross Profit

Biodesix income statement Correlations

Biodesix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biodesix income statement Accounts

Also Currently Popular

Additional Tools for Biodesix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Selling General Administrative
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Selling And Marketing Expenses	+ 0.99	Selling General Administrative
Total Operating Expenses	+ 0.99	Selling And Marketing Expenses
Ebit	+ 0.99	Operating Income

Interest Expense	- 0.97	Net Interest Income
Income Before Tax	- 0.95	Reconciled Depreciation
Income Before Tax	- 0.95	Total Operating Expenses
Total Operating Expenses	- 0.95	Ebit
Total Operating Expenses	- 0.95	Net Income From Continuing Ops
Income Tax Expense	- 0.94	Net Income